Columbus Venture Partners
Signal active
Investment Firm
Overview
Columbus Venture Partners is Spanish independent venture capital. It focuses on investing in early-stage opportunities in the life science industry.
The firm is a team of investment professionals with a scientific, medical, and business development background combined with experience in building and investing in companies to accelerate their commercialization.
Highlights
Founded
2015
Industry
Employees
11-50
Investment
16
Lead Investment
10
Exits
2
Stages
Early Stage Venture, Late Stage Venture, Seed
Investor Type
Venture Capital
Location
Europe
Contact Information
Social
Profile Resume
Columbus Venture Partners, established in 2015 and headquartered in Europe., specializes in Early Stage Venture, Late Stage Venture, Seed investments across Biotechnology, Health Care, Biopharma, Venture Capital, Finance, Therapeutics, Financial Services, Asset Management, Life Science, Health Diagnostics. The organization boasts a portfolio of 15 investments, with an average round size of $33.5M and 2 successful exits. Their recent investments include Vivet Therapeutics, Roche Venture Fund, Novartis Venture Fund, Ysios Capital, Kurma Partners. The highest investment round they participated in was $37.7B. Among their most notable exits are Vivet Therapeutics and Roche Venture Fund. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Columbus Venture Partners has made 16 investments. Their most recent investment was on Mar 05, 2024, when Multiverse Computing raised $27.1M.
Columbus Venture Partners has made 5 diversity investments. Their most recent diversity investment was on Aug 06, 2024, when Artax Biopharma raised $8.0M.
investments
16
Diversity investments
5
Lead investments
10
Number of exits
2
Investments
16
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Nov 03, 2023 | Cocoon Bioscience | Biotechnology | 2.1M |
| Feb 27, 2024 | Curve Therapeutics | Biotechnology | 51.4M |
| Mar 05, 2024 | Multiverse Computing | Software | 27.1M |
| Aug 06, 2024 | Artax Biopharma | Biotechnology | 8.0M |
Exits
2
Funding Timeline
Funding rounds
16
Investors
0
Funds
1
Funding Rounds
16
Columbus Venture Partners has raised 16 rounds. Their latest funding was raised on Aug 06, 2024 from a Convertible Note - Artax Biopharma round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Nov 03, 2023 | Venture Round - Cocoon Bioscience | - | 2.1M | - |
| Feb 27, 2024 | Series A - Curve Therapeutics | - | 51.4M | - |
| Mar 05, 2024 | Series A - Multiverse Computing | - | 27.1M | - |
| Aug 06, 2024 | Convertible Note - Artax Biopharma | - | 8.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.